{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:26:35Z","timestamp":1753892795184,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006556","name":"Centre Hospitalier Universitaire de Toulouse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>Neuropsychiatric disorders in childhood after prenatal drug exposure raises concerns. Most of the published studies focused on psychotropic medications. This study investigated which prenatal medication exposure was associated with neuropsychiatric disorders in childhood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A case-control study, nested in the French POMME cohort, was conducted to compare prenatal medication exposure between children with a history of neuropsychiatric care (ages 0\u20138 years) and children in a control group. POMME included children born in Haute-Garonne to women covered by the general Health Insurance System, between 2010 and 2011 (<jats:italic>N<\/jats:italic> = 8,372). Cases were identified through: (1) reimbursement for neuropsychiatric care; (2) psychomotor development abnormalities specified on health certificates; and (3) reimbursement for methylphenidate or neuroleptics. Controls had none of these criteria. Prenatal exposure to each of the major \u201cAnatomical Therapeutic Chemical\u201d classes was compared between the groups. Class(es) for which there was a statistically significant difference (after Bonferroni adjustment, i.e., p &amp;lt; <jats:italic>0.0033<\/jats:italic>) was(were) compared using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 723 (8.6%) cases and 4,924 (58.8%) controls were identified. This study showed a statistically significant difference in prenatal exposure to nervous system drugs (excluding analgesics) between the groups [ORa: 2.12 (1.55; 2.90)]. Differences (not statistically significant at the 0.0033 threshold) were also observed for the ATC classes: Musculoskeletal, Genito-urinary System and Sex Hormones, Alimentary Tract and Anti-infectives.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Through identification of children with neuropsychiatric disorders and of their prenatal medication exposure, this study provides guidance for the assessment of long-term neuropsychiatric effects after prenatal medication exposure, without focusing on psychotropic medications.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.795890","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T21:16:13Z","timestamp":1648415773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Justine","family":"Benevent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Hurault-Delarue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Revet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"first-page":"947","volume-title":"Diagnostic Diagnostic and Statistical Manual of Mental Disorders: DSM-5TM","year":"2013","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41390-018-0225-3","article-title":"Early origins of neuropsychiatric disorders","volume":"85","author":"Fleiss","year":"2019","journal-title":"Pediatr Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-014-0553-8","article-title":"The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison","volume":"24","author":"Atladottir","year":"2015","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/bdrc.21139","article-title":"Fetal programming of neuropsychiatric disorders","volume":"108","author":"Faa","year":"2016","journal-title":"Birth Defects Res Part C Embryo Today Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0181042","DOI":"10.1371\/journal.pone.0181042","article-title":"Association of prenatal exposure to benzodiazepines and child internalizing problems: a sibling-controlled cohort study","volume":"12","author":"Brandlistuen","year":"2017","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.seizure.2016.10.006","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes","volume":"44","author":"Bromley","year":"2017","journal-title":"Seizure."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00787-018-1177-1","article-title":"Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis","volume":"27","author":"Poels","year":"2018","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2017.3413","article-title":"Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring","volume":"317","author":"Sujan","year":"2017","journal-title":"JAMA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"j2350","DOI":"10.1136\/bmj.j2350","article-title":"Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study","volume":"357","author":"Man","year":"2017","journal-title":"BMJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e034829","DOI":"10.1136\/bmjopen-2019-034829","article-title":"Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study","volume":"10","author":"Bloti\u00e8re","year":"2020","journal-title":"BMJ Open."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.4088\/JCP.16f10789","article-title":"Major malformation risk, pregnancy outcomes, and neurodevelopmental outcomes associated with metformin use during pregnancy","volume":"77","author":"Andrade","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"B13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/nutrit\/nuy025","article-title":"Maternal oversupplementation with folic acid and its impact on neurodevelopment of offspring","volume":"76","author":"Murray","year":"2018","journal-title":"Nutr Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/acr.21888","article-title":"In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus","volume":"65","author":"Marder","year":"2013","journal-title":"Arthritis Care Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40264-018-0712-9","article-title":"POMME: the new cohort to evaluate long-term effects after prenatal medicine exposure","volume":"42","author":"Benevent","year":"2019","journal-title":"Drug Saf."},{"key":"B16","unstructured":"WHOCC - ATC\/DDD Index"},{"key":"B17","unstructured":"ICD-10 Version: 2019"},{"key":"B18","unstructured":"Les affections de longue dur\u00e9e (ALD) - Caisse nationale militaire de s\u00e9curit\u00e9 sociale"},{"key":"B19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.yebeh.2008.10.011","article-title":"The behavioral consequences of exposure to antiepileptic drugs in utero","volume":"14","year":"2009","journal-title":"Epilepsy Behav."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia."},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1192\/bjp.bp.113.127746","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children","volume":"205","author":"El Marroun","year":"2014","journal-title":"Br J Psychiatry J Ment Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4088\/JCP.13m08902","article-title":"Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes","volume":"75","author":"Santucci","year":"2014","journal-title":"J Clin Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am J Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4088\/JCP.10m06135","article-title":"A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure","volume":"72","author":"Suri","year":"2011","journal-title":"J Clin Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e600","DOI":"10.1542\/peds.2008-3655","article-title":"Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age","volume":"125","author":"Pedersen","year":"2010","journal-title":"Pediatrics."},{"key":"B28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ntt.2017.02.005","article-title":"Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: a population-based cohort study","volume":"61","author":"Radoj\u010di\u0107","year":"2017","journal-title":"Neurotoxicol Teratol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00228-014-1797-4","article-title":"Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age","volume":"71","author":"Odsbu","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e191435","DOI":"10.1001\/jamanetworkopen.2019.1435","article-title":"Association of maternal use of benzodiazepines and Z-hypnotics during pregnancy with motor and communication skills and attention-deficit\/hyperactivity disorder symptoms in preschoolers","volume":"2","author":"Lupattelli","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.ridd.2011.06.001","article-title":"The validity of psychiatric diagnoses: the case of \u201cspecific\u201d developmental disorders","volume":"32","author":"Dyck","year":"2011","journal-title":"Res Dev Disabil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/pds.4625","article-title":"Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children","volume":"28","author":"Markovic","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0221921","DOI":"10.1371\/journal.pone.0221921","article-title":"Prenatal antibiotics exposure and the risk of autism spectrum disorders: a population-based cohort study","volume":"14","author":"Hamad","year":"2019","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1007\/s10803-019-04093-y","article-title":"Early life exposure to antibiotics and autism spectrum disorders: a systematic review","volume":"49","author":"\u0141ukasik","year":"2019","journal-title":"J Autism Dev Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/dmcn.13557","article-title":"Children with neurodevelopmental disorders and disabilities: a population-based study of healthcare service utilization using administrative data","volume":"59","author":"Arim","year":"2017","journal-title":"Dev Med Child Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/fcp.12696","article-title":"Use of the French national health insurance information system for research in the field of mental health: systematic review and perspectives","volume":"36","author":"Revet","year":"2022","journal-title":"Fundam Clin Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.puhe.2015.07.036","article-title":"High prevalence of developmental delay among children under three years of age in poverty-stricken areas of China","volume":"129","author":"Wei","year":"2015","journal-title":"Public Health."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1542\/peds.2016-2828E","article-title":"Assessment of neurodevelopment, nutrition, and inflammation from fetal life to adolescence in low-resource settings","volume":"139","author":"Suchdev","year":"2017","journal-title":"Pediatrics."},{"key":"B40","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 - Trouble du spectre de l'autisme - Signes d'alerte rep\u00e9rage diagnostic et \u00e9valuation chez l'enfant et l'adolescent"},{"key":"B41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/JCP.0000000000000891","article-title":"Trends and patterns of antidepressant use in french children and adolescents from 2009 to 2016: a population-based study in the french health insurance database","volume":"38","author":"Revet","year":"2018","journal-title":"J Clin Psychopharmacol."},{"key":"B42","unstructured":"Les Enqu\u00eates Nationales P\u00e9rinatales - EPOP\u00e9"},{"key":"B43","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/clpt.2009.201","article-title":"Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence","volume":"86","author":"Oberlander","year":"2009","journal-title":"Clin Pharmacol Ther."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.795890\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T21:16:20Z","timestamp":1648415780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.795890\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":43,"alternative-id":["10.3389\/fpsyt.2022.795890"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.795890","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"article-number":"795890"}}